People: argenx SE (ARGX.OQ)

ARGX.OQ on NASDAQ Stock Exchange Global Select Market

2 Jul 2020
Change (% chg)

$0.86 (+0.38%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Lanthaler, Werner 

Dr. Werner Lanthaler Ph.D. serves as Non-Executive Independent Vice Chairman of the Board of the Company. Dr. Werner Lanthaler has served as a member of the Company's board of directors since July 2014. Dr. Lanthaler is the chief executive officer of Evotec AG, a global drug discovery research organization, a position he has held since March 2009. Dr. Lanthaler previously served on the supervisory boards of Bioxell SpA and Pantec Biosolutions AG. Dr. Lanthaler holds a degree in psychology from Universitaet Wien, a Ph. D. in business administration from Universitaet Wien of Economics and Business, and a Master’s degree in public administration from Harvard University. He is Chairman of the Audit Committee, and Member of the Remuneration and Nomination Committee of the Company.

Basic Compensation

Total Annual Compensation, EUR 712,170
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR --
Fiscal Year Total, EUR 712,170

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --